Drawing for AGMAVET

USPTO serial 87483703

AGMAVET

Reviewed by CopyMark Law Group

Reg. 5374959Status 702Registered
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
HOWARD, PARKER WALDRIP
Law office
TMO LAW OFFICE 117

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AGMAVET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Analgesic and muscle relaxant pharmaceutical preparations; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-epileptic pharmaceutical preparations; Anticonvulsants; Antidepressants; Chemotherapeutics; Clinical medical reagents; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritional supplements containing agmatine; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplements; Dietary supplements also containing agmatine; Dietary supplements consisting primarily of agmatine; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for treating nerve damage; Feed supplements for pets; Food supplements; Food supplements for treating nerve damage; Gels, creams and solutions for dermatological use; Glaucoma agents; Health food supplements; Homeopathic pharmaceuticals for use in the treatment of neuropathy; Homeopathic supplements; Medicaments for promoting recovery from nerve injury; Medicated animal feed; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated skin care preparations; Medicated supplements for foodstuffs for animals; Medicinal creams for skin care; Medicinal preparations for neuropathy; Natural dietary supplements; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for the treatment of neuropathy; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for promoting nerve health; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional supplements; Nutritional supplements consisting primarily of agmatine; Nutritional supplements for promoting healthy nerves; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the form of capsules; Nutritional supplements in the nature of nutritionally fortified soft chews; Ocular pharmaceuticals; Oral analgesics; Pain relief medication; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuropathy; Pharmaceutical preparations for the treatment and prevention of neuropathy; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of neuropathy; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for neuropathy; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, elixirs for the treatment of neuropathy; Pharmaceutical products for skin care for animals; Pharmaceuticals, namely, psychotropics; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Preparation for the relief of pain; Psychotropics; Syrups for pharmaceutical purposes for the treatment of neuropathy; Therapeutic pharmaceutical for the treatment of neuropathy; Topical analgesic creams; Veterinary preparations for dog neuropathy; Veterinary preparations, namely, pain relief medication; Vitamins and dietary food supplements for animalsACTIVEDec 27, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 18, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 18, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 21, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jan 9, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2017DOCKASSIGNED TO EXAMINER—
Jun 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 14, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance